.png){kind=icon}
.png){kind=icon}
Return
Fatty Pancreas and Risk of Type 2 Diabetes, Chronic Kidney Disease and Cardiovascular Events: Evidence From a Population-Based Cohort
.png){kind=icon}
OA
AI
N
O
A
V
R
A
S
DOI：10.1002/ueg2.70253.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Fatty pancreas is a metabolically active ectopic fat depot, but its cardiometabolic implications have been assessed using heterogeneous thresholds. We investigated the association of fatty pancreas, quantified using MRI-derived proton density fat fraction (PDFF) and categorised according to 2026 international consensus thresholds, with prevalent and incident type 2 diabetes (T2D), chronic kidney disease (CKD) and major adverse cardiovascular events (MACE).
Keywords:
beta cell dysfunction
cardiometabolic risk
ectopic fat
insulin resistance
metabolic risk stratification
pancreatic steatosis
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
6.7
Papers:
1.9K
Citations:
4.9K
Organization
Cited Papers